epigallocatechin gallate has been researched along with Cardiac Hypertrophy in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Y; Liu, G; Wang, Y | 1 |
| Liu, L; Luo, M; Mou, Q; Tian, J | 1 |
| Huang, X; Jia, Z; Liu, L; Luo, M; Mou, Q; Quan, J; Tian, J | 1 |
| Bi, XY; Cai, Y; Chen, TT; Gao, S; He, Y; Liu, PQ; Yan, TD; Ye, JT; Yu, SS; Zheng, GD | 1 |
| Albericio, G; Borralleras, C; Bosch-Morató, M; Campuzano, V; Guivernau, B; Muñoz, FJ; Ortiz-Romero, P; Pérez-Jurado, LA | 1 |
| Hu, Y; Li, J; Li, S; Li, Y; Ma, Y; Wen, J; Wu, J; Zhang, J; Zhang, L | 1 |
| Cui, W; Du, H; Li, N; Mao, W | 1 |
| Gu, ZL; Guo, CY; Sheng, R; Xie, ML; Zhou, WX | 2 |
| Gu, ZL; Sheng, R; Xie, ML | 1 |
| Ahn, HY; Kim, CH; Kim, EG; Kim, HS; Sachinidis, A; Song, HJ; Zheng, Y | 1 |
| Huang, Y; Hui, RT; Li, HL; Liang, CC; Liu, DP; Liu, G; Liu, YQ; Wang, AB; Wei, C; Wei, YS; Williams, GM; Zhang, CN | 1 |
| Ahn, HY; Ha, TS; Hao, J; Kim, CH | 1 |
13 other study(ies) available for epigallocatechin gallate and Cardiac Hypertrophy
| Article | Year |
|---|---|
Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway.
Topics: Animals; Cardiomegaly; Cardiotonic Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Male; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2021 |
Treg/Th17 Ratio Regulation May Play an Important Role in Epigallocatechin-3-Gallate-Mediated Attenuation of Increased Afterload-Induced Cardiac Hypertrophy.
Topics: Animals; Cardiomegaly; Catechin; Disease Models, Animal; Eosine Yellowish-(YS); Hematoxylin; Male; Mice; Mice, Inbred C57BL; T-Lymphocytes, Regulatory; Th17 Cells; Wheat Germ Agglutinins | 2022 |
Epigallocatechin-3-gallate exerts cardioprotective effects related to energy metabolism in pressure overload-induced cardiac dysfunction.
Topics: Animals; Cardiomegaly; Catechin; Disease Models, Animal; Energy Metabolism; Heart Failure; Myocardium; Rats; Reproducibility of Results | 2022 |
EGCG inhibits pressure overload-induced cardiac hypertrophy via the PSMB5/Nmnat2/SIRT6-dependent signalling pathways.
Topics: Animals; Cardiomegaly; Catechin; Cells, Cultured; Myocytes, Cardiac; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Sirtuins | 2021 |
Epigallocatechin-3-gallate improves cardiac hypertrophy and short-term memory deficits in a Williams-Beuren syndrome mouse model.
Topics: Animals; Cardiomegaly; Catechin; Disease Models, Animal; Memory Disorders; Memory, Short-Term; Mice; Mice, Mutant Strains; Williams Syndrome | 2018 |
Epigallocatechin-3-gallate inhibits angiotensin II-induced cardiomyocyte hypertrophy via regulating Hippo signaling pathway in H9c2 rat cardiomyocytes.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Catechin; Cell Line; Gene Expression Regulation; Molecular Structure; Myocytes, Cardiac; Natriuretic Peptide, Brain; Protein Serine-Threonine Kinases; Rats; Reactive Oxygen Species; Signal Transduction | 2019 |
[Inhibitory effect of tea polyphenols and EGCG on cultured hypertrophic myocyte induced by Ang II].
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Catechin; Cells, Cultured; Female; Flavonoids; Male; Myocytes, Cardiac; Phenols; Polyphenols; Rats; Rats, Wistar; Tea | 2008 |
EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy.
Topics: Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Camellia sinensis; Cardiomegaly; Catechin; Cell Proliferation; Disease Models, Animal; DNA-Binding Proteins; Dose-Response Relationship, Drug; Endothelins; Enzyme Inhibitors; Fibroblasts; Fibrosis; Hydroxyproline; Male; Myocardium; Nitric Oxide Synthase Type II; Nitrites; Organ Size; Plant Extracts; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Transcription Factors | 2009 |
Epigallocatechin gallate, the major component of polyphenols in green tea, inhibits telomere attrition mediated cardiomyocyte apoptosis in cardiac hypertrophy.
Topics: Animals; Apoptosis; Cardiomegaly; Catechin; Male; Myocytes, Cardiac; Polyphenols; Rats; Rats, Sprague-Dawley; Tea; Telomere | 2013 |
Inhibitory effect of epigallocatechin 3-O-gallate on vascular smooth muscle cell hypertrophy induced by angiotensin II.
Topics: Angiotensin II; Animals; Cardiomegaly; Catechin; Cells, Cultured; Male; Mitogen-Activated Protein Kinase Kinases; Muscle, Smooth, Vascular; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways.
Topics: Angiotensin II; Animals; Animals, Newborn; Antioxidants; Blotting, Northern; Blotting, Western; Cardiomegaly; Catechin; Electrophoretic Mobility Shift Assay; Enzyme Activation; ErbB Receptors; Hypertension; Male; MAP Kinase Kinase 4; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Transcription Factor AP-1 | 2006 |
EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats.
Topics: Animals; Apoptosis; Blood Pressure; Cardiomegaly; Catechin; Cell Survival; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocytes, Cardiac; Organ Size; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53 | 2007 |
Epigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats.
Topics: Animals; Blood Pressure; Cardiomegaly; Catechin; Echocardiography; Heart Rate; Histocytochemistry; Male; Organ Size; Rats; Rats, Sprague-Dawley | 2007 |